Comparison of two regimens of feeding and oral electrolyte solutions in infants with diarrhea

被引:3
作者
Goepp, JG
Katz, S
Cuervo, E
Reid, R
Moran, JR
Santosham, M
机构
[1] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT INT HLTH, BALTIMORE, MD USA
[2] MEAD JOHNSON RES CTR, EVANSVILLE, IN USA
关键词
cereal; dehydration; diarrhea; oral rehydration solutions; rehydration;
D O I
10.1097/00005176-199704000-00004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Glucose-based oral rehydration solutions (ORS) available in the United States do not appear to reduce the severity or duration of diarrhea. The use of cereal-derived ORS and cereal-based feedings appears to diminish the severity of illness in studies conducted in the developing world. To our knowledge, no controlled trials of cereal-derived ORS or cereal-based feedings have been performed in the United States. Methods: We performed a randomized, double-blind trial of two ORS feeding regimens in outpatients with diarrhea. Patients aged 2-13 months with acute watery diarrhea were enrolled. Subjects received standard glucose-based ORS in alternation with soy-based, lactose-free infant formula (Group 1) or rice syrup solid containing ORS in alternation with rice-based, lactose-free infant formula (Group 2). Subjects were visited at home daily to determine the severity of illness and characteristics of the stool. Results: After the first 2 days, significantly more Group 1 subjects continued to have diarrhea than did Group 2 subjects (median duration of diarrhea 3 vs. 2 days) as demonstrated by Kaplan-Meier survival curves (p = 0.04). Conclusion: We conclude that infants fed a regimen consisting of rice syrup solid containing ORS and rice formula resolved their diarrhea sooner than did infants fed a regimen of standard glucose-based ORS with soy formula. The relative contributions of ORS and formula to this more rapid recovery can be elucidated by further studies.
引用
收藏
页码:374 / 379
页数:6
相关论文
共 34 条
[31]   A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor [J].
Abbas, Richat ;
Hug, Bruce A. ;
Leister, Cathie ;
Sonnichsen, Daryl .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) :191-199
[32]   A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor [J].
Richat Abbas ;
Bruce A. Hug ;
Cathie Leister ;
Daryl Sonnichsen .
Cancer Chemotherapy and Pharmacology, 2012, 70 :191-199
[33]   Comparison of two forms of daily preventive zinc supplementation versus therapeutic zinc supplementation for diarrhea on young children's physical growth and risk of infection: Study design and rationale for a randomized controlled trial [J].
Wessells K.R. ;
Brown K.H. ;
Kounnavong S. ;
Barffour M.A. ;
Hinnouho G.-M. ;
Sayasone S. ;
Stephensen C.B. ;
Ratsavong K. ;
Larson C.P. ;
Arnold C.D. ;
Harding K.B. ;
Reinhart G.A. ;
Lertmemongkolchai G. ;
Fucharoen S. ;
Bernstein R.M. ;
Hess S.Y. .
BMC Nutrition, 4 (1)
[34]   A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants [J].
Ella, Raches ;
Babji, Sudhir ;
Ciarlet, Max ;
Blackwelder, William C. ;
Vadrevu, Krishna Mohan .
VACCINE, 2019, 37 (31) :4407-4413